SQSTM1/p62-Directed Metabolic Reprogramming Is Essential for Normal Neurodifferentiation
Summary: Neurodegenerative disorders are an increasingly common and irreversible burden on society, often affecting the aging population, but their etiology and disease mechanisms are poorly understood. Studying monogenic neurodegenerative diseases with known genetic cause provides an opportunity to...
Main Authors: | , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-04-01
|
Series: | Stem Cell Reports |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2213671119300256 |
id |
doaj-325a48b5ac9c47b4bce704a2ebf2353e |
---|---|
record_format |
Article |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Javier Calvo-Garrido Camilla Maffezzini Florian A. Schober Paula Clemente Elias Uhlin Malin Kele Henrik Stranneheim Nicole Lesko Helene Bruhn Per Svenningsson Anna Falk Anna Wedell Christoph Freyer Anna Wredenberg |
spellingShingle |
Javier Calvo-Garrido Camilla Maffezzini Florian A. Schober Paula Clemente Elias Uhlin Malin Kele Henrik Stranneheim Nicole Lesko Helene Bruhn Per Svenningsson Anna Falk Anna Wedell Christoph Freyer Anna Wredenberg SQSTM1/p62-Directed Metabolic Reprogramming Is Essential for Normal Neurodifferentiation Stem Cell Reports |
author_facet |
Javier Calvo-Garrido Camilla Maffezzini Florian A. Schober Paula Clemente Elias Uhlin Malin Kele Henrik Stranneheim Nicole Lesko Helene Bruhn Per Svenningsson Anna Falk Anna Wedell Christoph Freyer Anna Wredenberg |
author_sort |
Javier Calvo-Garrido |
title |
SQSTM1/p62-Directed Metabolic Reprogramming Is Essential for Normal Neurodifferentiation |
title_short |
SQSTM1/p62-Directed Metabolic Reprogramming Is Essential for Normal Neurodifferentiation |
title_full |
SQSTM1/p62-Directed Metabolic Reprogramming Is Essential for Normal Neurodifferentiation |
title_fullStr |
SQSTM1/p62-Directed Metabolic Reprogramming Is Essential for Normal Neurodifferentiation |
title_full_unstemmed |
SQSTM1/p62-Directed Metabolic Reprogramming Is Essential for Normal Neurodifferentiation |
title_sort |
sqstm1/p62-directed metabolic reprogramming is essential for normal neurodifferentiation |
publisher |
Elsevier |
series |
Stem Cell Reports |
issn |
2213-6711 |
publishDate |
2019-04-01 |
description |
Summary: Neurodegenerative disorders are an increasingly common and irreversible burden on society, often affecting the aging population, but their etiology and disease mechanisms are poorly understood. Studying monogenic neurodegenerative diseases with known genetic cause provides an opportunity to understand cellular mechanisms also affected in more complex disorders. We recently reported that loss-of-function mutations in the autophagy adaptor protein SQSTM1/p62 lead to a slowly progressive neurodegenerative disease presenting in childhood. To further elucidate the neuronal involvement, we studied the cellular consequences of loss of p62 in a neuroepithelial stem cell (NESC) model and differentiated neurons derived from reprogrammed p62 patient cells or by CRISPR/Cas9-directed gene editing in NESCs. Transcriptomic and proteomic analyses suggest that p62 is essential for neuronal differentiation by controlling the metabolic shift from aerobic glycolysis to oxidative phosphorylation required for neuronal maturation. This shift is blocked by the failure to sufficiently downregulate lactate dehydrogenase expression due to the loss of p62, possibly through impaired Hif-1α downregulation and increased sensitivity to oxidative stress. The findings imply an important role for p62 in neuronal energy metabolism and particularly in the regulation of the shift between glycolysis and oxidative phosphorylation required for normal neurodifferentiation. : SQSTM1/p62 is a known autophagy adaptor that, if lost, causes childhood-onset neurodegeneration. Data from Wredenberg et al. show that loss of p62 in a neuronal stem cell model does not affect mitophagy but instead leads to impaired differentiation. The authors suggest p62 finely tunes LDHA expression and thus controls the metabolic shift to OXPHOS required for proper differentiation. Keywords: SQSTM1, p62, hypoxia, mitochondria, neurodifferentiation, neuroepithelial-like stem cells, neuronal development, oxidative stress, mitophagy, neurodegeneration |
url |
http://www.sciencedirect.com/science/article/pii/S2213671119300256 |
work_keys_str_mv |
AT javiercalvogarrido sqstm1p62directedmetabolicreprogrammingisessentialfornormalneurodifferentiation AT camillamaffezzini sqstm1p62directedmetabolicreprogrammingisessentialfornormalneurodifferentiation AT florianaschober sqstm1p62directedmetabolicreprogrammingisessentialfornormalneurodifferentiation AT paulaclemente sqstm1p62directedmetabolicreprogrammingisessentialfornormalneurodifferentiation AT eliasuhlin sqstm1p62directedmetabolicreprogrammingisessentialfornormalneurodifferentiation AT malinkele sqstm1p62directedmetabolicreprogrammingisessentialfornormalneurodifferentiation AT henrikstranneheim sqstm1p62directedmetabolicreprogrammingisessentialfornormalneurodifferentiation AT nicolelesko sqstm1p62directedmetabolicreprogrammingisessentialfornormalneurodifferentiation AT helenebruhn sqstm1p62directedmetabolicreprogrammingisessentialfornormalneurodifferentiation AT persvenningsson sqstm1p62directedmetabolicreprogrammingisessentialfornormalneurodifferentiation AT annafalk sqstm1p62directedmetabolicreprogrammingisessentialfornormalneurodifferentiation AT annawedell sqstm1p62directedmetabolicreprogrammingisessentialfornormalneurodifferentiation AT christophfreyer sqstm1p62directedmetabolicreprogrammingisessentialfornormalneurodifferentiation AT annawredenberg sqstm1p62directedmetabolicreprogrammingisessentialfornormalneurodifferentiation |
_version_ |
1725437834349772800 |
spelling |
doaj-325a48b5ac9c47b4bce704a2ebf2353e2020-11-25T00:02:25ZengElsevierStem Cell Reports2213-67112019-04-01124696711SQSTM1/p62-Directed Metabolic Reprogramming Is Essential for Normal NeurodifferentiationJavier Calvo-Garrido0Camilla Maffezzini1Florian A. Schober2Paula Clemente3Elias Uhlin4Malin Kele5Henrik Stranneheim6Nicole Lesko7Helene Bruhn8Per Svenningsson9Anna Falk10Anna Wedell11Christoph Freyer12Anna Wredenberg13Max Planck Institute Biology of Ageing - Karolinska Institutet Laboratory, Karolinska Institutet, 171 65 Stockholm, Sweden; Department of Molecular Medicine and Surgery, Karolinska Institutet, 171 76 Stockholm, SwedenMax Planck Institute Biology of Ageing - Karolinska Institutet Laboratory, Karolinska Institutet, 171 65 Stockholm, Sweden; Department of Medical Biochemistry and Biophysics, Karolinska Institutet, 171 65 Stockholm, SwedenMax Planck Institute Biology of Ageing - Karolinska Institutet Laboratory, Karolinska Institutet, 171 65 Stockholm, Sweden; Department of Molecular Medicine and Surgery, Karolinska Institutet, 171 76 Stockholm, SwedenMax Planck Institute Biology of Ageing - Karolinska Institutet Laboratory, Karolinska Institutet, 171 65 Stockholm, Sweden; Department of Medical Biochemistry and Biophysics, Karolinska Institutet, 171 65 Stockholm, SwedenDepartment of Neuroscience, Karolinska Institutet, 171 65 Stockholm, SwedenDepartment of Neuroscience, Karolinska Institutet, 171 65 Stockholm, SwedenDepartment of Molecular Medicine and Surgery, Karolinska Institutet, 171 76 Stockholm, Sweden; Centre for Inherited Metabolic Diseases, Karolinska University Hospital, 171 76 Stockholm, SwedenDepartment of Medical Biochemistry and Biophysics, Karolinska Institutet, 171 65 Stockholm, Sweden; Centre for Inherited Metabolic Diseases, Karolinska University Hospital, 171 76 Stockholm, SwedenDepartment of Medical Biochemistry and Biophysics, Karolinska Institutet, 171 65 Stockholm, Sweden; Centre for Inherited Metabolic Diseases, Karolinska University Hospital, 171 76 Stockholm, SwedenDepartment of Clinical Neuroscience, Karolinska Institutet, 171 76 Stockholm, SwedenDepartment of Neuroscience, Karolinska Institutet, 171 65 Stockholm, SwedenMax Planck Institute Biology of Ageing - Karolinska Institutet Laboratory, Karolinska Institutet, 171 65 Stockholm, Sweden; Department of Molecular Medicine and Surgery, Karolinska Institutet, 171 76 Stockholm, Sweden; Centre for Inherited Metabolic Diseases, Karolinska University Hospital, 171 76 Stockholm, SwedenMax Planck Institute Biology of Ageing - Karolinska Institutet Laboratory, Karolinska Institutet, 171 65 Stockholm, Sweden; Department of Medical Biochemistry and Biophysics, Karolinska Institutet, 171 65 Stockholm, Sweden; Centre for Inherited Metabolic Diseases, Karolinska University Hospital, 171 76 Stockholm, Sweden; Corresponding authorMax Planck Institute Biology of Ageing - Karolinska Institutet Laboratory, Karolinska Institutet, 171 65 Stockholm, Sweden; Department of Medical Biochemistry and Biophysics, Karolinska Institutet, 171 65 Stockholm, Sweden; Centre for Inherited Metabolic Diseases, Karolinska University Hospital, 171 76 Stockholm, Sweden; Corresponding authorSummary: Neurodegenerative disorders are an increasingly common and irreversible burden on society, often affecting the aging population, but their etiology and disease mechanisms are poorly understood. Studying monogenic neurodegenerative diseases with known genetic cause provides an opportunity to understand cellular mechanisms also affected in more complex disorders. We recently reported that loss-of-function mutations in the autophagy adaptor protein SQSTM1/p62 lead to a slowly progressive neurodegenerative disease presenting in childhood. To further elucidate the neuronal involvement, we studied the cellular consequences of loss of p62 in a neuroepithelial stem cell (NESC) model and differentiated neurons derived from reprogrammed p62 patient cells or by CRISPR/Cas9-directed gene editing in NESCs. Transcriptomic and proteomic analyses suggest that p62 is essential for neuronal differentiation by controlling the metabolic shift from aerobic glycolysis to oxidative phosphorylation required for neuronal maturation. This shift is blocked by the failure to sufficiently downregulate lactate dehydrogenase expression due to the loss of p62, possibly through impaired Hif-1α downregulation and increased sensitivity to oxidative stress. The findings imply an important role for p62 in neuronal energy metabolism and particularly in the regulation of the shift between glycolysis and oxidative phosphorylation required for normal neurodifferentiation. : SQSTM1/p62 is a known autophagy adaptor that, if lost, causes childhood-onset neurodegeneration. Data from Wredenberg et al. show that loss of p62 in a neuronal stem cell model does not affect mitophagy but instead leads to impaired differentiation. The authors suggest p62 finely tunes LDHA expression and thus controls the metabolic shift to OXPHOS required for proper differentiation. Keywords: SQSTM1, p62, hypoxia, mitochondria, neurodifferentiation, neuroepithelial-like stem cells, neuronal development, oxidative stress, mitophagy, neurodegenerationhttp://www.sciencedirect.com/science/article/pii/S2213671119300256 |